M Pharmaceutical Inc. Engages Camargo Pharmaceutical Services To Develop Regulatory Strategy For Newly Acquired Chelatexx Technology
Camargo Pharmaceutical Services | October 11, 2016
M Pharmaceutical Inc., (the "Company" or “M Pharma”), is pleased to announce that it has engaged Camargo Pharmaceutical Services, in order to help C-103 is a novel formulation of Orlistat, patented until 2030 in the United States.